Up to date lists of publications can be found on Google Scholar and Pubmed
2024
Kamalova A, Manoocheri K, Liu X, Casello SM, Huang M, Baimel C, Jang EV, Anastasiades PG, Collins DP, Carter AG (2024). CCK+ interneurons contribute to thalamus-evoked feed-forward inhibition in prelimbic prefrontal cortex. Journal of Neuroscience. Read it here.
2023
Longo F, Aryal S, Anastasiades PG, Maltese M, Baimel C, Albanese F, Tabor J, Zhu J, Oliveira MM, Gastaldo D, Bagni C, Santini E, Tritsch N, Carter AG, Klann E (2023). Cell type-specific disruption of cortico-striatal circuitry drives repetitive and perseverative behaviors in fragile X syndrome model mice.. Cell Reports.. Read it here.
Naef L, Seabrook L, Baimel C, Judge AK, Kenney T, Ellis M, Qiao M, Floresco SB, Borgland SL (2023). Disinhibition of the orbitofrontal cortex biases goal-directed behaviour in obesity. Nature Neuroscience. Read it here.
2022
Baimel C, Jang E, Scudder SL, Manoocheri K, Carter AG (2022). Hippocampal-evoked inhibition of cholinergic interneurons in the nucleus accumbens. Cell Reports. Read it here.
Thomas CS, Mohammadkhani A, Rana M, Qiao M, Baimel C, Borgland SL (2022). Optogenetic stimulation of lateral hypothalamic orexin/dynorphin inputs in the ventral tegmental area potentiates mesolimbic dopamine neurotransmission and promotes reward-seeking behaviours. Neuropsychopharmacology. Read it here.
2019
Baimel C, McGarry LM, Carter AG (2019). The projection targets of medium spiny neurons govern cocaine-evoked synaptic plasticity in the nucleus accumbens. Cell Reports. Read it here.
2018
Scudder SL, Baimel C, Macdonald EE, Carter AG (2018). Hippocampal-evoked feedforward inhibition in the nucleus accumbens. Journal of Neuroscience. Read it here.
Thomas TS, Baimel C, Borgland SL (2018). Opioid and hypocretin neuromodulation of ventral tegmental area neuronal subpopulations. British Journal of Pharmacology. Read it here.
Lam VM, Mielnik CA, Baimel C, Beerepoot P, Espinoza S, Sukhanov I, Horsfall W, Gainetdinov RR, Borgland SL, Ramsey AJ, Salahpour A (2018). Behavioral effects of a potential novel TAAR1 antagonist. Frontiers in Pharmacology.
2017
Baimel C, Lau BK, Qiao M, Borgland SL (2017). Projection-target defined effects of orexin and dynorphin on VTA dopamine neurons. Cell Reports. Read it here.
Burma NE, Bonin RP, Leduc-Pessah H, Baimel C, Cairncross ZF, Mousseau M, Shankara JV, Stemkowski PL, Baimoukhametova D, Bains JS, Antle MC, Zamponi GW, Cahill CM, Borgland SL, De Koninck Y, Trang T (2017). Blocking Microglial pannexin-1 channel alleviates morphine withdrawal in rodents. Nature Medicine. Read it here.
Baimel C, Borgland SL (2017). Hypocretin/orexin and plastic adaptations associated with drug abuse. Current Topics in Behavioral Neuroscence. Read it here.
Thompson JL, Drysdale M, Baimel C, Kaur M, MacGowan T, Pitman KA, Borgland SL (2017). Obesity-induced structural and neuronal plasticity in the lateral orbitofrontal cortex. Neuropsychopharmacology. Read it here.
2015
Thompson J, Yang J, Lau, B, Liu S, Baimel C, Kerr L, Fang L, Borgland SL (2015). Age dependent D1-D2 receptor co-activation in the lateral orbitofrontal cortex potentiates NMDA receptors and facilitates cognitive flexibility. Cerebral Cortex. Read it here.
Baimel C, Borgland SL (2015). Orexin signaling in the VTA gates morphine-induced synaptic plasticity. Journal of Neuroscience. Read it here.
2014
Baimel C, Bartlett SE, Chiou LC, Lawrence AJ, Muschamp JW, Patkar O, Tung LW, Borgland SL (2014). Orexin/hypocretin role in reward: implications for opioid and other addictions. British Journal of Pharmacology. Read it here.
2012
Kmiotek E, Baimel C, Gill KJ (2012). Methods for intravenous self-administration in a mouse model. Journal of Visualized Experiments.
Baimel C, Borgland SL (2012). Hypocretin modulation of drug-induced synaptic plasticity. Progress in Brain Research.
Baimel C, Borgland SL, Corrigal W (2012). Cocaine and nicotine research illustrates a range of hypocretin mechanisms in addiction. Vitamins and Hormones.